Edges in Network
| Network | GSE16446_egf1520 - GSE16446 - SiGN-BN HC+Bootstrap |
| Network Description | Predicting the efficacy of anthracyclines in breast cancer (BC) patients: The results of the TOP trial |
| Node | PTAFR |
| Upstream (Parents) |
|---|
| (<<) CASP8 → PTAFR |
| (<<) CD4 → PTAFR |
| (<<) CORO1A → PTAFR |
| (<<) GLRX → PTAFR |
| (<<) GRN → PTAFR |
| (<<) HLA-DOA → PTAFR |
| (<<) HLA-G → PTAFR |
| (<<) KLK3 → PTAFR |
| (<<) LPXN → PTAFR |
| (<<) RAB5C → PTAFR |
| (<<) RAC2 → PTAFR |
| (<<) RHOF → PTAFR |
| (<<) UBE2L6 → PTAFR |
| Downstream (Children) |
|---|
| PTAFR → AKT2 (>>) |
| PTAFR → APH1B (>>) |
| PTAFR → BCL2A1 (>>) |
| PTAFR → CHST11 (>>) |
| PTAFR → CYP27B1 (>>) |
| PTAFR → DHRS9 (>>) |
| PTAFR → GPX1 (>>) |
| PTAFR → GSTK1 (>>) |
| PTAFR → HMOX1 (>>) |
| PTAFR → HSD11B1 (>>) |
| PTAFR → IFITM3 (>>) |
| PTAFR → IL1RN (>>) |
| PTAFR → ITGB7 (>>) |
| PTAFR → LCP1 (>>) |
| PTAFR → LRP6 (>>) |
| PTAFR → MERTK (>>) |
| PTAFR → MPP1 (>>) |
| PTAFR → MYL6B (>>) |
| PTAFR → MYO10 (>>) |
| PTAFR → SOD2 (>>) |
| PTAFR → SPATA2L (>>) |
| PTAFR → STAT1 (>>) |
| PTAFR → SYNJ2 (>>) |
| PTAFR → TGM2 (>>) |
| PTAFR → TINF2 (>>) |
| PTAFR → VANGL1 (>>) |
